You are here: Industry Insights > Novavax

News List

Novavax Files for Emergency Use of COVID-19 Vaccine in the UAE AmericanPharmaceuticalReview
December 14, 2021
Novavax, Inc. has submitted a regulatory filing to the Ministry of Health and Prevention (MoHaP) for emergency use of its COVID-19 vaccine in the United Arab Emirates (UAE).
Novavax says it could start making Omicron-specific vaccine in January expresspharma
December 03, 2021
Other vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots.
Novavax seeks interim authorisation for Covid-19 vaccine in Singapore Pharmaceutical-Technology
November 26, 2021
US-based biotechnology firm Novavax has filed an application seeking interim authorisation from the Singapore Health Sciences Authority (HSA) for its Covid-19 vaccine, NVX-CoV2373, under the Pandemic Special Access Route.
Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore prnewswire
November 25, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced its submission...
Philippine FDA grants EUA to Novavax’s Covid-19 vaccine Pharmaceutical-Technology
November 19, 2021
The Philippine Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Novavax’s Covid-19 vaccine, NVX-CoV2373, for active immunisation of people aged 18 years and above.
Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization prnasia
November 18, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that...
EMA Begins Evaluation of Novavax' COVID-19 Vaccine ContractPharma
November 18, 2021
Novavax, Inc. announced that European Medicines Agency (EMA) has begun its evaluation of an application for conditional marketing authorization (CMA) for its COVID-19 vaccine...
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines prnewswire
November 18, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII)...
Alcami Inks Lab Services Agreement with Novavax ContractPharma
November 17, 2021
Alcami, a U.S.-based CDMO, has signed a master laboratory services agreement with Novavax, a biotechnology company developing next-generation vaccines for infectious diseases.
Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373 prnasia
November 16, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited (SK bioscience)...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page